SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-165,487
-120,011
-91,248
-68,512
-50,785
Depreciation & amortization
15,816
28,409
27,972
26,492
31,869
Deferred income taxes
-1,480
31
-
-
-
Stock based compensation
21,291
17,483
15,139
12,412
12,084
Change in working capital
6,040
21,902
8,132
-17,900
1,337
Accounts receivable
25,071
2,844
7,694
-9,494
40,245
Inventory
537
3,390
4,318
-5,800
1,863
Accounts Payable
-13,846
11,382
-
-
-
Other working capital
-103,457
-65,160
-39,320
-40,537
6,521
Other non-cash items
890
219
-4,267
739
4,574
Net cash provided by operating activites
-99,505
-62,403
-38,855
-40,459
6,744
Cash flows from investing activities
Investments in property, plant and equipment
-3,952
-2,757
-465
-78
-223
Acquisitions, net
-
0
-
-
-
Purchases of investments
-127,564
0
-15
-
-
Sales/Maturities of investments
-
-
0
0
3,061
Other investing activites
158,765
4,130
-601
-601
0
Net cash used for investing activites
32,323
1,373
-1,081
-679
2,838
Cash flows from financing activities
Debt repayment
-
-20
-27,500
-9,014
-
Common stock issued
1,814
0
134,759
74,537
2,109
Common stock repurchased
-
-
-4,331
-1,397
-638
Dividends Paid
-
0
0
-6
-
Other financing activites
-
-23,034
-27,189
-5,030
0
Net cash used privided by (used for) financing activities
15,158
-8,457
108,721
59,644
1,471
Net change in cash
-52,100
-69,843
69,101
18,481
9,799
Cash at beginning of period
174,371
227,323
158,222
139,741
129,942
Cash at end of period
122,347
157,480
227,323
158,222
139,741
Free Cash Flow
Operating Cash Flow
-99,505
-62,403
-38,855
-40,459
6,744
Capital Expenditure
-3,952
-2,757
-465
-78
-223
Free Cash Flow
-103,457
-65,160
-39,320
-40,537
6,521